News & Updates
-
OCRA Funded Study Aims to Increase Efficacy of PARP Inhibitors
(March 20, 2019) The Ovarian Cancer Dream Team, funded in part by OCRA, recently completed a Phase 1b Trial, which combined a PARP inhibitor with an HRR (homologous recombination repair) pathway…
-
OCRA Spring Advocacy Day 2019 Actions
(March 20, 2019) Earlier this month, OCRA united advocates from across the country for Spring Advocacy Day on Capitol Hill…
-
Action Alert: Tell Congress to Increase OCRP Funding
(March 19, 2019) Congress is considering a $15 million increase for OCRP funding. Urge YOUR Representative to sign the letter to help push this funding through…
-
OCRA-Funded Research Indicates that Stem-Like Cells May Be Key to Preventing Recurrence
(March 15, 2019) Cell Reports recently published a study about a drug that, given in combination with chemotherapy, could greatly increase survival rates of ovarian cancer patients…
-
Remembering Lori Newcomb
(March 1, 2019) OCRA mourns the loss of our beloved board member and friend, Lori Newcomb…
-
OCRA’s Ovarian Cancer National Conference® Registration is Now Open
Curious about the status of ovarian cancer research and treatments? Want to meet other survivors? You need to attend OCRA’s Ovarian Cancer National Conference…
Help Save Women's Lives
Our Impact
-
Invested over $85M
in ovarian cancer research since 1998
-
Educated 75,000+
future medical professionals since 2002
-
Advocated for $150M+
in government research funding in 2018
Fundraise for OCRA
-
Do It Yourself
Create your own unique fundraiser to help end ovarian cancer.
-
Ovarian Cycle
Start or join an Ovarian Cycle® ride in your town and spin for a cure!
Check out our calendar for an upcoming event near you!